RUA Life Sciences (GB:RUA) has released an update.
RUA Life Sciences has strategically expanded its contract manufacturing business with the acquisition of Analytic Biosurgical Solutions SAS (Abiss), a company specializing in implantable medical devices, for €80,000. Abiss, which was not in liquidation despite its parent company’s insolvency, has a strong track record with innovative surgical implants, owns intellectual property rights, and has a growing contract manufacture business. This acquisition is set to bolster RUA’s medium-term growth targets and complements its existing customer relationships and reputation for quality in the medical device sector.
For further insights into GB:RUA stock, check out TipRanks’ Stock Analysis page.
